- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | CF PHARMTECH (02652): NEXT DAY DISCLOSURE RETURN | 5 | HKEx | ||
| 24.12.25 | CF PHARMTECH (02652): VOLUNTARY ANNOUNCEMENT SELECTION OF A COMPANY-LED PROJECT INTO THE 2025 JIANGSU PROVINCIAL MAJOR SCIENCE AND TECHNOLOGY PROGRAM ... | 2 | HKEx | ||
| 17.12.25 | CF PHARMTECH (02652): VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPLICATION FOR OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE MONOHYDRATE NASAL SPRAY ACCEPTED ... | 1 | HKEx | ||
| 16.12.25 | CF PHARMTECH (02652): POLL RESULTS OF 2025 FIRST EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 26.11.25 | CF PHARMTECH (02652): FORM OF PROXY FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDAY, DECEMBER 16, 2025 | 1 | HKEx | ||
| CF PHARMTECH Aktie jetzt für 0€ handeln | |||||
| 26.11.25 | CF PHARMTECH (02652): NOTICE OF 2025 FIRST EXTRAORDINARY GENERAL MEETING | - | HKEx | ||
| 26.11.25 | CF PHARMTECH (02652): PROPOSED SHARE REPURCHASE MANDATE PROPOSED ADOPTION OF H SHARE AWARD SCHEME PROPOSED AUTHORIZATION TO THE BOARD AND/OR AUTHORIZED ... | - | HKEx | ||
| 26.11.25 | CF PHARMTECH (02652): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS | - | HKEx | ||
| 26.11.25 | CF PHARMTECH (02652): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS | 1 | HKEx | ||
| 25.11.25 | CF PHARMTECH (02652): INSIDE INFORMATION PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION BY THE COMPANY | - | HKEx | ||
| 13.11.25 | CF PHARMTECH (02652): VOLUNTARY ANNOUNCEMENT PROPOSED SHARE REPURCHASE MANDATE | 1 | HKEx | ||
| 13.11.25 | CF PHARMTECH (02652): PROPOSED ADOPTION OF H SHARE AWARD SCHEME PROPOSED AUTHORIZATION TO THE BOARD AND/OR AUTHORIZED PERSON TO HANDLE MATTERS RELATING ... | 1 | HKEx | ||
| 08.10.25 | BRIEF: Heavily oversubscribed CF PharmTech triples in Hong Kong trading debut | 1 | Bamboo Works | ||
| 06.10.25 | CF PHARMTECH (02652): ANNOUNCEMENT OF ALLOTMENT RESULTS | 2 | HKEx | ||
| 06.10.25 | CF PHARMTECH (02652): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 06.10.25 | CF PHARMTECH (02652): TERMS OF REFERENCE AND RULES OF PROCEDURE FOR THE NOMINATION COMMITTEE | 1 | HKEx | ||
| 06.10.25 | CF PHARMTECH (02652): TERMS OF REFERENCE AND RULES OF PROCEDURE FOR THE REMUNERATION AND APPRAISAL COMMITTEE | 1 | HKEx | ||
| 06.10.25 | CF PHARMTECH (02652): TERMS OF REFERENCE AND RULES OF PROCEDURE FOR THE AUDIT COMMITTEE | - | HKEx | ||
| 06.10.25 | CF PHARMTECH (02652): ARTICLES OF ASSOCIATION | 2 | HKEx | ||
| 26.09.25 | BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO | 1 | Bamboo Works |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen CF PHARMTECH INC kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CF PHARMTECH INC finden Sie auf Wallstreet Online.